Sirio Pharma Co., Ltd. (300791.SZ)
CNY 28.09
(-0.46%)
CNY 28.09
(-0.46%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 795.88 Million CNY | 32.0% |
| 2022 | 522.4 Million CNY | 8.76% |
| 2021 | 480.32 Million CNY | 30.17% |
| 2020 | 368.99 Million CNY | 2.91% |
| 2019 | 358.56 Million CNY | 19.8% |
| 2018 | 299.29 Million CNY | 6.43% |
| 2017 | 281.22 Million CNY | 39.76% |
| 2016 | 201.22 Million CNY | -24.38% |
| 2015 | 266.08 Million CNY | 17.01% |
| 2014 | 227.4 Million CNY | 24.36% |
| 2013 | 182.85 Million CNY | 49.15% |
| 2012 | 122.59 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 199.04 Million CNY | 11.88% |
| 2024 Q3 | 212.25 Million CNY | 15.19% |
| 2024 Q2 | 207.8 Million CNY | 4.4% |
| 2023 Q1 | 160.21 Million CNY | -0.68% |
| 2023 FY | 689.58 Million CNY | 32.0% |
| 2023 Q4 | 177.9 Million CNY | -2.6% |
| 2023 Q3 | 182.64 Million CNY | 8.19% |
| 2023 Q2 | 168.81 Million CNY | 5.37% |
| 2022 FY | 522.4 Million CNY | 8.76% |
| 2022 Q4 | 161.31 Million CNY | 23.72% |
| 2022 Q2 | 132.54 Million CNY | 35.03% |
| 2022 Q1 | 98.16 Million CNY | -31.87% |
| 2022 Q3 | 130.38 Million CNY | -1.63% |
| 2021 FY | 480.32 Million CNY | 30.17% |
| 2021 Q1 | 106.51 Million CNY | 11.43% |
| 2021 Q2 | 117.79 Million CNY | 10.59% |
| 2021 Q3 | 111.92 Million CNY | -4.98% |
| 2021 Q4 | 144.08 Million CNY | 28.73% |
| 2020 Q2 | 103.82 Million CNY | 54.53% |
| 2020 Q4 | 95.59 Million CNY | -6.64% |
| 2020 Q1 | 67.18 Million CNY | -41.8% |
| 2020 Q3 | 102.39 Million CNY | -1.38% |
| 2020 FY | 368.99 Million CNY | 2.91% |
| 2019 Q3 | 84.34 Million CNY | 1.06% |
| 2019 FY | 358.56 Million CNY | 19.8% |
| 2019 Q1 | 75.32 Million CNY | -6.71% |
| 2019 Q2 | 83.46 Million CNY | 10.81% |
| 2019 Q4 | 115.42 Million CNY | 36.85% |
| 2018 Q4 | 80.74 Million CNY | 11.99% |
| 2018 Q3 | 72.09 Million CNY | 0.0% |
| 2018 FY | 299.29 Million CNY | 6.43% |
| 2017 FY | 281.22 Million CNY | 39.76% |
| 2016 FY | 201.22 Million CNY | -24.38% |
| 2015 Q4 | 88.38 Million CNY | 0.0% |
| 2015 FY | 266.08 Million CNY | 17.01% |
| 2014 FY | 227.4 Million CNY | 24.36% |
| 2013 FY | 182.85 Million CNY | 49.15% |
| 2012 FY | 122.59 Million CNY | 0.0% |